Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n‐3 and n‐6 polyunsaturated fatty acidsBianca M. Arendt, Johane P. Allard, Elena M. Comelli et al.|Hepatology|2015Cited by 348
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)Henry Lik‐Yuen Chan, Elizabeth Cooney, Seng Gee Lim et al.|Journal of Hepatology|2015Cited by 106
Non-Alcoholic Fatty Liver Disease in HIV Infection Associated with Altered Hepatic Fatty Acid CompositionBianca M. Arendt, Johane P. Allard, E. Jenny Heathcote et al.|Current HIV Research|2011Cited by 16